Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
The Missing Charter Statement: Why Hasn’t the Government Explained How Bill C-34’s Social Media Ban Complies with the Charter? 
Three Years After October 7th: Living With the Shockwaves 
What If the U.S. Demanded This? The Cloud Provider Conditions Behind Canada’s EU Digital Pivot 
Ontario is Done Waiting for Universities to Act on Campus Antisemitism 
Is Compromise on Encryption Possible? Why Bill C-22’s “Minor Opening” Leaves the Central Question Unanswered
